Day: January 26, 2026

TORONTO, Jan. 26, 2026 (GLOBE NEWSWIRE) — Sprott Asset Management LP (“Sprott Asset Management”), a subsidiary of Sprott Inc., on behalf of the Sprott Physical Uranium Trust (TSX: U.UN) (TSX: U.U) (the “Trust”), a non-redeemable investment fund created to invest and hold substantially all of its assets in physical uranium, today announced that it has updated its at-the-market equity program to issue up to U.S.$1.0 billion of units of the Trust (“Units”) in Canada. Distributions under the at-the-market equity program in Canada (the “ATM Program”) will be completed in accordance with the terms of an amended and restated sales agreement dated December 6, 2024 (the “Sales Agreement”) between Sprott Asset Management (as the manager of the Trust), the Trust, Cantor Fitzgerald Canada Corporation (“Cantor”), Virtu Canada Corp. (“Virtu”),...

OMA SAVINGS BANK PLC, PRESS RELEASE 26 JANUARY 2026 AT  16:25 P.M Save the Date Capital Markets Day in Helsinki – 19 May 2026 Oma Savings Bank Plc (OmaSp) is pleased to invite investors, analysts and media representatives to its Capital Markets Day. Date: Monday, 19 May 2026 Format: Hybrid event in Helsinki (in-person and live webcast) The Capital Markets Day will provide an in-depth overview of OmaSp’s strategy, business priorities and long-term value creation. Senior management will present the company’s strategic direction, financial targets and market outlook. Further details, including the agenda and registration information, will be shared closer to the event. The event will be held in English. We look forward to welcoming you. Oma Savings Bank Plc Investor Relations

LAS VEGAS, Jan. 26, 2026 (GLOBE NEWSWIRE) — Galaxy Gaming, Inc. (OTC:GLXZ), a leading developer and distributor of casino table games and technology, is thrilled to announce the official UK launch of MONOPOLY Table Games Progressive, starting with the installation of MONOPOLY Blackjack Progressive across premier Metropolitan Casinos in London, including Metropolitan Mayfair, Empire Casino, The Sportsman Casino, and Park Lane Club. This milestone marks the debut of MONOPOLY-branded progressive table games in the UK, bringing one of the world’s most iconic brands to life in the casino pit. Through an exclusive licensing agreement with Hasbro, Inc. (NASDAQ:HAS), a leading games, IP and toy entertainment company, Galaxy Gaming is the sole table games licensee for MONOPOLY, enabling the company to deliver innovative experiences that...

Strategic Cost Discipline and Organic Growth Focus Drive Improved Capital Efficiency and Support Path Toward Cash Flow Positivity Celebration, FL , Jan. 26, 2026 (GLOBE NEWSWIRE) — La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech enterprise, today reported that it has reduced its cash burn over the past 30 days by approximately 25% compared to its average quarterly cash burn during fiscal year 2025. This improvement reflects the impact of higher-margin revenue initiatives implemented in late 2025, with the majority of these initiatives taking effect on December 15, 2025 and January 1, 2026. The reduction reflects the Company’s continued focus on operating discipline, cost optimization, and improved operating leverage following a strategic shift toward organic growth. Management attributes...

Revenue of $3.6 Million, an increase of 72% over prior year Operating income increased 201% Gross profit increased 99.7% Net Income increased 185%ASHLAND, Ky., Jan. 26, 2026 (GLOBE NEWSWIRE) — TX Rail Products, Inc. (OTC Markets PINK: TXRP), a supplier of rail and rail products to the U.S. coal mining industry, short line railroads and tunneling contractors, today announced financial results for the first quarter of fiscal year 2026. Mr. Shrewsbury, CEO and Chairman commented, “We delivered a strong start to fiscal 2026, marked by substantial revenue growth and significantly improved profitability. Demand across our core rail markets remained robust, allowing us to expand margins while maintaining disciplined cost control. Our ability to generate meaningful operating cash flow while scaling the business reflects the strength...

                                                                        Ress Life Investments A/SNybrogade 12DK-1203 Copenhagen KDenmarkCVR nr. 33593163www.resslifeinvestments.com To: Nasdaq CopenhagenDate: 26 January 2026 Corporate Announcement 03/2026 Ress Life Investments A/S announces the events of the extraordinary general meeting held on 26 January 2026. At the extraordinary general meeting of Ress Life Investments A/S held on Monday 26 January 2026, the following decisions were taken:Amendment of the Company’s Articles of Association by suspending the running of notice periods for redemption in the period from 1 January 2026 to 31 December 2026 – cf. item 1 of the agenda. Amendment of the Company’s Articles of Association by removing the appointment of Resscapital AB as the Company’s Fund Manager –...

Company successfully completes genesis mint of Standard Gold Coins, marking key operational milestone NEW YORK, Jan. 26, 2026 (GLOBE NEWSWIRE) — Blue Gold Limited (Nasdaq: BGL) (“Blue Gold” or the “Company”), a next-generation gold development and technology company, today announced that it has successfully completed the first minting of its genesis Standard Gold Coins (SGC), marking a significant milestone in the operational rollout of its gold-backed digital asset framework. Each SGC corresponds to one gram of fully allocated physical gold, minted only upon verified custody intake and subject to defined compliance and authorization procedures. The initial minting represents the first issuance of SGC fully backed by allocated physical gold held in professional custody, in accordance with the governance, reserve management, and...

ELPIS II top-line trial results are anticipated in the third quarter of 2026 Laromestrocel Biological License Application (BLA) submission for full traditional approval for HLHS anticipated if ELPIS II results are positive U.S. FDA has awarded laromestrocel HLHS program Rare Pediatric Disease designation, Orphan Drug designation, and Fast Track designation Laromestrocel HLHS program has the potential to address an unmet medical need with significant U.S. market opportunities Even with current standard of care surgeries, only 50% of infants survive to adolescence due to right ventricular failureMIAMI, Jan. 26, 2026 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that...